BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28795366)

  • 1. Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation.
    Pires WC; Lima BAV; de Castro Pereira F; Lima AP; Mello-Andrade F; Silva HD; da Silva MM; Colina-Vegas L; Ellena J; Batista AA; de Paul Silveira-Lacerda E
    Mol Cell Biochem; 2018 Jan; 438(1-2):199-217. PubMed ID: 28795366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).
    Pereira Fde C; Lima BA; de Lima AP; Pires WC; Monteiro T; Magalhães LF; Costa W; Graminha AE; Batista AA; Ellena J; Siveira-Lacerda Ede P
    J Inorg Biochem; 2015 Aug; 149():91-101. PubMed ID: 25873134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-[RuCl(BzCN)(bipy)(dppe)]PF6 induces anti-angiogenesis and apoptosis by a mechanism of caspase-dependent involving DNA damage, PARP activation, and Tp53 induction in Ehrlich tumor cells.
    Magalhães LF; Mello-Andrade F; Pires WC; Silva HD; da Silva PFF; Macedo LM; Henrique de Castro C; Carneiro CC; Cardoso CG; de Melo Reis PR; Camargo de Oliveira L; Caetano RR; Batista AA; Silveira-Lacerda EP
    Chem Biol Interact; 2017 Dec; 278():101-113. PubMed ID: 28935426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiparasitic activities of novel ruthenium/lapachol complexes.
    Barbosa MI; Corrêa RS; de Oliveira KM; Rodrigues C; Ellena J; Nascimento OR; Rocha VP; Nonato FR; Macedo TS; Barbosa-Filho JM; Soares MB; Batista AA
    J Inorg Biochem; 2014 Jul; 136():33-9. PubMed ID: 24727183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η
    Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU
    J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, DNA interaction, antioxidant and anticancer activity studies of ruthenium(II) polypyridyl complexes.
    Jiang GB; Xie YY; Lin GJ; Huang HL; Liang ZH; Liu YJ
    J Photochem Photobiol B; 2013 Dec; 129():48-56. PubMed ID: 24177204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
    PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium(II)/Benzonitrile Complex Induces Cytotoxic Effect in Sarcoma-180 Cells by Caspase-Mediated and Tp53/p21-Mediated Apoptosis, with Moderate Brine Shrimp Toxicity.
    Faria RS; Silva HD; Mello-Andrade F; Pires WC; de Castro Pereira F; de Lima AP; de Fátima Oliveira Santos S; Teixeira TM; da Silva PFF; Naves PLF; Batista AA; da Silva Oliveira RJ; Reis RM; de Paula Silveira-Lacerda E
    Biol Trace Elem Res; 2020 Dec; 198(2):669-680. PubMed ID: 32266641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruthenium(II) complexes: DNA-binding, cytotoxicity, apoptosis, cellular localization, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential and western blot analysis.
    Li W; Jiang GB; Yao JH; Wang XZ; Wang J; Han BJ; Xie YY; Lin GJ; Huang HL; Liu YJ
    J Photochem Photobiol B; 2014 Nov; 140():94-104. PubMed ID: 25108205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
    Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T
    Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF-6[dppb=1,4-bis(diphenylphosphine)butane and bipy=2,2'-bipyridine].
    Carnizello AP; Barbosa MI; Martins M; Ferreira NH; Oliveira PF; Magalhães GM; Batista AA; Tavares DC
    J Inorg Biochem; 2016 Nov; 164():42-48. PubMed ID: 27613330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway.
    Graminha AE; Popolin C; Honorato de Araujo-Neto J; Correa RS; de Oliveira KM; Godoy LR; Vegas LC; Ellena J; Batista AA; Cominetti MR
    Eur J Med Chem; 2022 Dec; 243():114772. PubMed ID: 36191406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The trans-[Ru(PPh
    Becceneri AB; Popolin CP; Plutin AM; Maistro EL; Castellano EE; Batista AA; Cominetti MR
    J Inorg Biochem; 2018 Sep; 186():70-84. PubMed ID: 29857173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ru(II)-Based Amino Acid Complexes Show Promise for Leukemia Treatment: Cytotoxicity and Some Light on their Mechanism of Action.
    de Lima AP; Almeida MAP; Mello-Andrade F; de Castro Pereira F; Pires WC; Abreu DC; de Souza Velozo-Sá V; Batista AA; de Paula Silveira-Lacerda E
    Biol Trace Elem Res; 2020 Sep; 197(1):123-131. PubMed ID: 31773484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway.
    Jiang GB; Zheng X; Yao JH; Han BJ; Li W; Wang J; Huang HL; Liu YJ
    J Inorg Biochem; 2014 Dec; 141():170-179. PubMed ID: 25268891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.
    Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ
    J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer.
    Oliveira KM; Peterson EJ; Carroccia MC; Cominetti MR; Deflon VM; Farrell NP; Batista AA; Correa RS
    Dalton Trans; 2020 Nov; 49(45):16193-16203. PubMed ID: 32329497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets.
    Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA
    Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis.
    Colina-Vegas L; Dutra JL; Villarreal W; de A Neto JH; Cominetti MR; Pavan F; Navarro M; Batista AA
    J Inorg Biochem; 2016 Sep; 162():135-145. PubMed ID: 27383651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor Effect of Organometallic Half-Sandwich Ru(II)-Arene Complexes Bearing a Glutathione
    Han T; Wu Y; Han W; Yan K; Zhao J; Sun Y
    Inorg Chem; 2021 Sep; 60(17):13051-13061. PubMed ID: 34369147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.